Kamal, S., Varshney, K., Uayan, D. J. F., & Caliwag, F. M. C. (2024). Evaluating Efficacy of Vedolizumab, Ustekinumab, and Golimumab in the Management of Inflammatory Bowel Disease and the Combined Role of Nutritional Therapy with Biologics: A Review. Biologics, 4(3), 280. https://doi.org/10.3390/biologics4030018
Chicago Style (17th ed.) CitationKamal, Shahed, Karan Varshney, Danielle Josefa F. Uayan, and Fides Myles C. Caliwag. "Evaluating Efficacy of Vedolizumab, Ustekinumab, and Golimumab in the Management of Inflammatory Bowel Disease and the Combined Role of Nutritional Therapy with Biologics: A Review." Biologics 4, no. 3 (2024): 280. https://doi.org/10.3390/biologics4030018.
MLA (9th ed.) CitationKamal, Shahed, et al. "Evaluating Efficacy of Vedolizumab, Ustekinumab, and Golimumab in the Management of Inflammatory Bowel Disease and the Combined Role of Nutritional Therapy with Biologics: A Review." Biologics, vol. 4, no. 3, 2024, p. 280, https://doi.org/10.3390/biologics4030018.